These benefits, along with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant disorders. Researchers believe that blocking this https://michaelo369url8.sharebyblog.com/profile